Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 1038984, 8 pages
https://doi.org/10.1155/2017/1038984
Research Article

Negative Correlation between miR-200c and Decorin Plays an Important Role in the Pathogenesis of Colorectal Carcinoma

1Shanghai Starriver Bilingual School, 2588 Jindu Road, Minhang District, Shanghai 201108, China
2Department of General Surgery, Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
3Shanghai Cinoasia Institute, Yangpu District, Shanghai 200437, China

Correspondence should be addressed to Hong-Qi Chen; moc.361@80nehcqh and Si-Bo Zhu; moc.aisaonic@uhzobis

Received 10 October 2016; Accepted 16 March 2017; Published 16 April 2017

Academic Editor: Stephen H. Safe

Copyright © 2017 Ren-Yi Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, C. Desantis, and A. Jemal, “Colorectal cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 2, pp. 104–117, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Fritzmann, M. Morkel, D. Besser et al., “A colorectal cancer expression profile that includes transforming growth factor β inhibitor BAMBI predicts metastatic potential,” Gastroenterology, vol. 137, no. 1, pp. 165–175, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Bettegowda, M. Sausen, R. J. Leary et al., “Detection of circulating tumor DNA in early- and late-stage human malignancies,” Science Translational Medicine, vol. 6, no. 224, Article ID 224ra24, 2014. View at Publisher · View at Google Scholar
  4. C. A. Metildi, S. Kaushal, G. A. Luiken, M. A. Talamini, R. M. Hoffman, and M. Bouvet, “Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model,” Journal of Surgical Oncology, vol. 109, no. 5, pp. 451–458, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Hu, J. Chen, T. Tian et al., “Genetic variants of miRNA sequences and non-small cell lung cancer survival,” The Journal of Clinical Investigation, vol. 118, no. 7, pp. 2600–2608, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Petrillo, G. F. Zannoni, L. Beltrame et al., “Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies,” Annals of Oncology, vol. 27, no. 4, pp. 625–634, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Wang, Y. Du, X. Liu, W. C. Cho, and Y. Yang, “MicroRNAs as regulator of signaling networks in metastatic colon cancer,” BioMed Research International, vol. 2015, Article ID 823620, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Wang, S. Guan, F. Liu et al., “Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma,” British Journal of Cancer, vol. 114, no. 3, pp. 290–297, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Callegari, B. K. Elamin, F. Giannone et al., “Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model,” Hepatology, vol. 56, no. 3, pp. 1025–1033, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. M. M. Gits, P. F. Van Kuijk, M. B. E. Jonkers et al., “MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours,” British Journal of Cancer, vol. 109, no. 6, pp. 1625–1635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Berindan-Neagoe, P. D. C. Monroig, B. Pasculli, and G. A. Calin, “MicroRNAome genome: A treasure for cancer diagnosis and therapy,” CA Cancer Journal for Clinicians, vol. 64, no. 5, pp. 311–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. Calin, C. D. Dumitru, M. Shimizu et al., “Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15524–15529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Chen, W. Wang, Y. Zhang, T. Hu, and Y. Chen, “The roles of miR-200c in colon cancer and associated molecular mechanisms,” Tumor Biology, vol. 35, no. 7, pp. 6475–6483, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. The Cancer Genome Atlas Network, “Comprehensive molecular characterization of human colon and rectal cancer,” Nature, vol. 487, no. 7407, pp. 330–337, 2012. View at Publisher · View at Google Scholar
  15. F. Yang, L. Zhang, X.-S. Huo et al., “Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans,” Hepatology, vol. 54, no. 5, pp. 1679–1689, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Shannon, A. Markiel, O. Ozier et al., “Cytoscape: a software environment for integrated models of biomolecular interaction networks,” Genome Research, vol. 13, no. 11, pp. 2498–2504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kanehisa, Y. Sato, M. Kawashima, M. Furumichi, and M. Tanabe, “KEGG as a reference resource for gene and protein annotation,” Nucleic Acids Research, vol. 44, no. 1, pp. D457–D462, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Mlakar, G. Berginc, M. Volavšek, Z. Štor, M. Rems, and D. Glavač, “Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer,” BMC Cancer, vol. 9, article 282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Chen, L. S. Liang, and X. K. Wang, “MiR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1,” Clinical and Experimental Metastasis, vol. 29, no. 5, pp. 457–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Prislei, E. Martinelli, M. Mariani et al., “MiR-200c and HuR in ovarian cancer,” BMC Cancer, vol. 13, article 72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Bai, D.-S. Dong, and L. Pei, “Synergistic antitumor activity of resveratrol and miR-200c in human lung cancer,” Oncology Reports, vol. 31, no. 5, pp. 2293–2297, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. B.-P. Chang, D.-S. Wang, J.-W. Xing, S.-H. Yang, Q. Chu, and S.-Y. Yu, “MiR-200c inhibits metastasis of breast cancer cells by targeting HMGB1,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 34, no. 2, pp. 201–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Song, L.-Z. Liu, X.-Q. Pei et al., “miR-200c inhibits breast cancer proliferation by targeting KRAS,” Oncotarget, vol. 6, no. 33, pp. 34968–34978, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. Nash, M. T. Deavers, and R. S. Freedman, “The expression of decorin in human ovarian tumors,” Clinical Cancer Research, vol. 8, no. 6, pp. 1754–1760, 2002. View at Google Scholar · View at Scopus
  25. H. Tang, M. Deng, Y. Tang et al., “MiR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression,” Clinical Cancer Research, vol. 19, no. 20, pp. 5602–5612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Jurmeister, M. Baumann, A. Balwierz et al., “MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F,” Molecular and Cellular Biology, vol. 32, no. 3, pp. 633–651, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Saydam, Y. Shen, T. Würdinger et al., “Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/β-catenin signaling pathway,” Molecular and Cellular Biology, vol. 29, no. 21, pp. 5923–5940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Pichler, A. L. Ress, E. Winter et al., “MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients,” British Journal of Cancer, vol. 110, no. 6, pp. 1614–1621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Jang, H. Ahn, J. Sim et al., “Loss of microRNA-200a expression correlates with tumor progression in breast cancer,” Translational Research, vol. 163, no. 3, pp. 242–251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. B. A. Teicher, Y. Maehara, Y. Kakeji et al., “Reversal of in vivo drug resistance by the transforming growth factor-β inhibitor decorin,” International Journal of Cancer, vol. 71, no. 1, pp. 49–58, 1997. View at Google Scholar · View at Scopus
  31. L. F. Brown, A. J. Guidi, S. J. Schnitt et al., “Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast,” Clinical Cancer Research, vol. 5, no. 5, pp. 1041–1056, 1999. View at Google Scholar · View at Scopus
  32. M. Santra, T. Skorski, B. Calabretta, E. C. Lattime, and R. V. Iozzo, “De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 15, pp. 7016–7020, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. C. C. Reed, A. Waterhouse, S. Kirby et al., “Decorin prevents metastatic spreading of breast cancer,” Oncogene, vol. 24, no. 6, pp. 1104–1110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Köninger, N. A. Giese, F. F. Di Mola et al., “Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action,” Clinical Cancer Research, vol. 10, no. 14, pp. 4776–4783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Yu, Y. Li, B. Zhang et al., “Suppression of mTOR signaling pathways in skeletal muscle of finishing pigs by increasing the ratios of ether extract and neutral detergent fiber at the expense of starch in iso-energetic diets,” Journal of Agricultural and Food Chemistry, vol. 64, no. 7, pp. 1557–1564, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Wu, W. Li, C. Lin et al., “Co-regulation of the Notch and Wnt signaling pathways promotes supporting cell proliferation and hair cell regeneration in mouse utricles,” Scientific Reports, vol. 6, article 29418, 2016. View at Publisher · View at Google Scholar · View at Scopus